The size of the space genomics and transcriptomics market is

LOS ANGELES, September 29, 2022 (GLOBE NEWSWIRE) – The Global Space genomics and transcriptomics market The size represented $ 184 million in 2021 and is estimated to reach a market size of $ 389 million by 2030, growing at a CAGR of 8.9% from 2022 to 2030.

Market statistics of space genomics and transcriptomics

  • Global space genomics and transcriptomics market revenue was $ 184 million in 2021, with a CAGR of 8.9% from 2022 to 2030
  • North America region leads with over 44% market share of space genomics and transcriptomics in 2021
  • The Europe region is expected to expand at a 9% CAGR from 2022 to 2030
  • Among technologies, the space transcriptomics segment captured 80% of the total market in 2021
  • By product, the consumables segment accounted for more than 50% of the revenue share in 2021

Request a free sample report @ https://www.acumenresearchandconsulting.com/request-sample/1532

Spatial Genomics and Transcriptomics Market Report Coverage:

Market Space genomics and transcriptomics market
Space genomics and transcriptomics market Size 2021 184 million dollars
Space genomics and transcriptomics market 2030 forecast 389 million dollars
Space genomics and transcriptomics market CAGR In the period 2022 – 2030 8.9%
Space genomics and transcriptomics market Analysis period 2018 – 2030
Space genomics and transcriptomics market Reference year 2021
Space genomics and transcriptomics market Forecast data 2022 – 2030
Segments covered By product, by technology, by end use and by geography
Space genomics and transcriptomics market Regional scope North America, Europe, Asia Pacific, Latin America and the Middle East and Africa
Key profiled companies NanoString Technologies, 10x Genomics, CARTANA AB, Horizon Discovery Group plc, Illumina, Inc., S2 Genomics, Inc., Dovetail Genomics, Seven Bridges Genomic and Advanced Cell Diagnostics.
Report coverage Market Trends, Drivers, Restrictions, Competitive Analysis, Player Profiling, Regulation Analysis

Market overview of space genomics and transcriptomics

Spatial genomics and transcriptomics allow researchers to visualize not only what is inside a cell, but also how cells are structured in relation to each other, providing crucial information about the disease through the use of data that were previously beyond the reach of current methodologies. Transcriptomics investigation and assortment are included in space genomics and transcriptomics.

Growth factors of the space genomics and transcriptomics market

  • Growing potential of spatial genomic analysis as a cancer diagnosis technique
  • Increase drug development and discovery efforts by pharmaceutical companies
  • The launch of new products and their awareness on the part of customers

Spatial genomics and transcriptomics. Market dynamics

Current improvements in genetic tools, as well as increased investment in genomes and transcriptome research, are the main drivers of market expansion in the cumulative demand for viable diagnostic alternatives for cancer. In addition, new and start-up genomics companies are attempting to meet the growing demand for sophisticated technologies to explore space models by developing new products.

For example, GeoMx Digitally Spatial Profiler is scheduled for 2019 by NanoString Technologies. Additionally, companies are forming strategic alliances to tap into untapped market potential. Spatial Transcriptomics and Seven Bridges partnered in April 2017 to create a comprehensive visualization tool for monitoring gene expression within tissue samples.

In disease management, space genomics has excellent potential as it helps provide information on quantitative gene expression, along with visualized mapping of DNA and RNA within parts of the tissue. In turn, this generates profitable opportunities for companies to introduce spatially resolved diagnostic and translational research transcriptomics and genomics-based techniques.

Market share of space genomics and transcriptomics

In translation theory, space genomics and transcriptomics generated the largest share of revenue in 2018. Key providers provide scientists with various channels for evaluation in genetic investigations, as well as access and revenue generation for biomedical data on a large scale. Current research on the morphometric status of cells during the diagnosis of disorders offers university clients substantial opportunities for business growth.

See the detailed summary of the report @

https://www.acumenresearchandconsulting.com/table-of-content/spatial-genomics-and-transcriptomics-market

Market segmentation of space genomics and transcriptomics

The global space genomics and transcriptomics market has been segmented by Acumen Research and Consulting based on product, technology and end use. By product, the segment is divided into tools [by type (IHC, sequencing platforms, mass spectrometry, microscopy, flow cytometry, and others), and by mode (manual, semi-automated, and automated)]Software [imaging tools, bioinformatics tools, and storage and management databases]and consumables. Consumables accounted for the largest percentage of revenues thanks to greater product penetration and the widespread availability of reagents and kits for carrying out investigations. At the same time, strategic partnerships between players, such as Illumina’s Edico Genome acquisition in May 2018 to accelerate the evaluation of genetic information, result in a faster rate of software product development.

In terms of technology, the market is further classified into space transcriptomics [sequencing-based methods (in situ sequencing, laser capture microdissection (LCM), microtomy sequencing, and transcriptome in-vivo analysis (TIVA)), microscopy-based RNA imaging techniques (padlock probes/ rolling circle amplification, single molecule RNA fluorescence in-situ hybridization, and branched DNA probes), and IHC]and Space genomics [microscopy-based live DNA Imaging, FISH, massively-parallel sequencing, genome perturbation tools, biochemical techniques, and others]. Advances in genome destruction tools promote the use of FISH, resulting in the highest percentage of technology profits. Parallel processing sequencing, on the other hand, results in increased production at low cost and it is likely that segment advancement will soon be complemented by a rapid CAGR. Furthermore, the huge number of sequence platforms available for studying RNA architecture in tissues or cells was critical for spatial transcriptomics. However, IHC approaches are expected to have the greatest commercial penetration because they are not well suited to space omics investigations but have low-performance sequencing.

Based on the end use, the industry is further divided into pharmaceutical manufacturer, translational research, academic clients, and diagnostic clients. According to the forecasts of the space genomics and transcriptomics market, the pharmaceutical manufacturers segment is expected to grow significantly in the market in the forecast years.

Regional overview of the space genomics and transcriptomics market

The global space genomics and transcriptomics market is divided into several geographic regions: North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. According to the analysis of the space genomics and transcriptomics sector, North America leads the global market and is expected to maintain its largest sales share in 2021. The company continues to invest in cancer research due to strong demand in the United States of best diagnostic and therapeutic approaches.

On top of that, the Asia-Pacific region is expected to have the largest market growth during the forecast period. Geographic expansion and the creation of low-cost manufacturing and operating facilities in the growing economies of the region are activities from established areas.

Purchase this premium research report –

https://www.acumenresearchandconsulting.com/buy-now/0/1532

Players in the space genomics and transcriptomics market

Some of the leading space genomics and transcriptomics market companies are NanoString Technologies, S2 Genomics, Inc., CARTANA AB, Illumina, Inc., Dovetail Genomics, Seven Bridges Genomic, 10x Genomics, Horizon Discovery Group plc, and Advanced Cell Diagnostics.

Market strategies of space genomics and transcriptomics

  • Mature organizations are working on new platforms to maintain their position in the market. Government assistance helps new entrants expand their product offerings. S2 Genomics, for example, received a Phase I STTR grant from the National Institute of Health in June 2018 for the development of a unique system to simplify the manufacture of individual kernels.

Questions this report answers

  • – What was the market size of the Space Genomics and Transcriptomics market in 2021?
  • What will be the CAGR of the Space Genomics and Transcriptomics market during the forecast period from 2022 to 2030?
  • Who are the major global players in this Space Genomics and Transcriptomics market?
  • Which region held the largest share in the space genomics and transcriptomics market in 2021?
  • What are the main market drivers of the Space Genomics and Transcriptomics Market?
  • Who is the largest market for space genomics and transcriptomics end users?
  • What will be the market value of space genomics and transcriptomics in 2030?

Browse other research topics on Healthcare sector:

The global Market for anastomosis devices accounted for 2,219 million dollars in 2020 and is expected to reach 3,822 million dollars by 2028 with a notable 7.1% CAGR in the forecast period from 2021 to 2028.

The global Human Chorionic Gonadotropin Market accounted for 874 million dollars in 2020 and is expected to reach 1,534 million dollars by 2028 with a notable 7.4% CAGR in the period foreseen from 2021 to 2028.

The global Biliary stent market accounted for approx 345 million dollars in 2020 and is expected to reach 510 million dollars by 2028 with a notable 5.3% CAGR in the forecast period from 2021 to 2028.

Of Acumen Research and Consulting:

Acumen Research and Consulting is a global provider of market information and consulting services for the information technology, investment, telecommunications, manufacturing and consumer technology markets. ARC helps investment communities, IT professionals and business executives make fact-based decisions about technology purchases and develop business growth strategies to compete in the marketplace. With the team size of over 100 analysts and collective industry experience of over 200 years, Acumen Research and Consulting ensures to deliver a combination of industry knowledge along with global and national expertise.

For the latest update follow us on Twitter And, LinkedIn

Contact us:

Mr. Richard Johnson

Acumen Research and Consulting

USA: +13474743864

India: +918983225533

E-mail: sales@acumenresearchandconsulting.com

    .

Leave a Reply

%d bloggers like this: